PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […]

Related Keywords

United States , Raymond James , Matthewb Klein , Jeromeb Zeldis , Charles Schwab Investment Management Inc , Citigroup , Vise Technologies Inc , Jefferies Financial Group , Nasdaq , Goldman Sachs Group , Therapeutics Inc , Rathbones Group , Therapeutics Company Profile , Walleye Capital , Securities Exchange Commission , Get Free Report , Financial Group , Exchange Commission , Director Jerome , Schwab Investment Management , Get Free ,